| |
| |
|
| Insider
Information: |
Blobel Friedhelm |
| Relationship: |
President, CEO, Direct... |
| City: |
San Mateo |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sciclone Pharmaceuticals Inc |
SCLN |
President, CEO, Direct... |
2017-10-13 |
0 |
2007-11-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2016-04-11 |
4 |
D |
$12.39 |
$5,027,490 |
D/D |
(405,770) |
459,282 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2016-08-17 |
4 |
S |
$10.00 |
$5,018,750 |
D/D |
(501,875) |
86,380 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President, CEO, Director |
• • – |
2017-10-13 |
4 |
D |
$11.18 |
$4,330,003 |
D/D |
(387,299) |
0 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2016-04-11 |
4 |
OE |
$2.49 |
$1,642,902 |
D/D |
659,800 |
765,792 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2012-06-14 |
4 |
S |
$7.01 |
$781,330 |
D/D |
(111,000) |
36,018 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-06-20 |
4 |
AS |
$10.90 |
$763,627 |
D/D |
(70,000) |
122,209 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2016-12-21 |
4 |
AS |
$10.54 |
$666,619 |
D/D |
(63,099) |
86,784 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2016-11-21 |
4 |
AS |
$10.22 |
$570,913 |
D/D |
(55,853) |
86,784 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-06-30 |
4 |
AS |
$11.00 |
$385,484 |
D/D |
(35,044) |
122,209 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2016-10-27 |
4 |
AS |
$9.30 |
$371,892 |
D/D |
(40,000) |
86,784 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2014-05-14 |
4 |
D |
$4.79 |
$327,641 |
D/D |
(68,401) |
163,652 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2015-05-14 |
4 |
D |
$9.13 |
$321,339 |
D/D |
(35,196) |
132,456 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2016-08-12 |
4 |
D |
$10.41 |
$317,786 |
D/D |
(30,527) |
488,255 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-03-21 |
4 |
AS |
$9.51 |
$288,496 |
D/D |
(30,338) |
92,526 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-06-12 |
4 |
D |
$10.75 |
$280,468 |
D/D |
(26,090) |
122,209 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-01-24 |
4 |
AS |
$10.41 |
$271,986 |
D/D |
(25,925) |
86,784 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2016-11-14 |
4 |
AS |
$10.33 |
$255,086 |
D/D |
(24,699) |
86,784 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-06-20 |
4 |
OE |
$3.55 |
$248,500 |
D/D |
70,000 |
162,209 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-01-23 |
4 |
AS |
$10.41 |
$237,508 |
D/D |
(22,807) |
86,784 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-08-15 |
4 |
D |
$11.05 |
$230,636 |
D/D |
(20,872) |
141,337 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-06-08 |
4 |
AS |
$11.00 |
$219,608 |
D/D |
(19,956) |
93,299 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2015-07-06 |
4 |
AS |
$10.80 |
$215,912 |
D/D |
(20,000) |
202,273 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-02-21 |
4 |
AS |
$9.86 |
$198,956 |
D/D |
(20,176) |
86,784 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-06-07 |
4 |
AS |
$10.03 |
$197,524 |
D/D |
(19,700) |
93,299 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
President & CEO |
• • – |
2017-05-11 |
4 |
AS |
$10.00 |
$182,315 |
D/D |
(18,226) |
92,526 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
